NSE:GLAND - Gland Pharma Stock Price & Analysis

About Gland Pharma (NSE:GLAND)

(NSE:GLAND) Gland Pharma Limited engages in the development, manufacture, and marketing of injectable-focused generic liquid parenteral products. The company's primary molecules include heparin sodium, enoxaparin sodium, rocuronium bromide, and daptomycin injections, as well as others. It offers its products under various therapeutic categories, such as anti-infectives, anesthetics, anti-coagulants and their antidotes, anti-malarial, cardiology, gastro-intestinal, hormones and related drugs, fertility supplements, Gnrh agonists and antagonists, anti-neoplastic, gynecological, neuro/Cns, respiratory, blood related, ophthalmological and otological, pain/analgesics, orthopedics, hematinic, vitamins/minerals/nutrients, and others. The company also provides contract development services. It sells its products primarily under a business to business in the United States, Europe, Canada, Australia, India, and the rest of the world. The company was founded in 1978 and is based in Hyderabad, India. As of October 3, 2017, Gland Pharma Limited operates as a subsidiary of Fosun Pharma Industrial Pte. Ltd.

GLAND Stock Price

Statistics Highlights (NSE:GLAND)

Shares Outstanding	164.58M	Beta	-
Public Float	57.13M	P/E Ratio	42.24
% Short of Float	-	Dividend (Yield)	-
Held by Insiders	61.96%	Ex-Dividend Date
Held by Institutions	17.90%	IPO Date	-

Explore More on "Statistics" Section

GLAND Financial Summary

|

	Mar 21	Mar 20	Mar 19
Revenue	INR34.24B	INR25.72B	INR19.93B
EBITDA	INR14.37B	INR10.94B	INR7.71B
Net Income	INR9.97B	INR7.73B	INR4.52B
Total Assets	INR64.96B	INR40.86B	INR35.24B
Total Cash	INR4.92B	INR1.69B	INR2.36B
Total Debt	INR49.95M	INR60.11M	INR66.31M

	Dec 21	Sep 21	Jun 21
Revenue	INR10.63B	INR10.80B	INR11.54B
EBITDA	INR3.95B	INR4.28B	INR4.98B
Net Income	INR2.73B	INR3.02B	INR3.51B
Total Assets	INR	INR73.98B	INR
Total Cash	INR	INR2.72B	INR
Total Debt	INR	INR47.93M	INR

GLAND Stock Price History

Gland Pharma Annual Stock Price History

Year	Open	Close	Change
2021	INR3873.00	INR3340.25	-13.76%
2021	INR2344.90	INR3873.00	65.17%

Gland Pharma Daily Stock Price History

Date	Open	High	Low	Close	Change	Volume
Jun 15, 2022	INR2696.00	INR2730.45	INR2622.00	INR2666.00	3.61%	173.04K
Jun 22, 2022	INR2652.00	INR2689.50	INR2558.05	INR2573.15	-2.67%	109.15K
Jun 24, 2022	INR2647.25	INR2651.95	INR2596.85	INR2643.65	-6.08%	101.83K

View More on "Price History" Section

(NSE:GLAND) Stock Price FAQs

What is today's stock price of Gland Pharma (NSE:GLAND)?

The current stock price of Gland Pharma (NSE:GLAND) is INR3340.25.
Today GLAND stock price opened at INR3429.85 after previous close of INR3448.70.
During the day, Gland Pharma stock quote has varied from a low of INR3319.00 to a high of INR3429.85.

What is Gland Pharma's 52-week change?

GLAND 52-week high stock quote is INR4350.00, which is 30.20% above the current share price.
The Gland Pharma (NSE:GLAND) 52-week low stock price is INR2750.00, which is 17.70% below the current share price.

Gland Pharma (NSE:GLAND) FAQ

How Much is Gland pharma Worth?

Gland pharma's worth today based on market capitalisation is INR502.62B

How much dividend does Gland pharma Pay?

The current annualized dividend payout for GLAND stock is INR0.00, the dividend yield is 0.00% and the payout ratio is 0.00%.
View More Details on Gland pharma's "Dividend" Section

What is Gland pharma’s Price to Earning (PE) ratio?

Gland pharma has a Price to Earning (P/E) ratio of 42.24. GLAND stock also has a Price to Sales (P/S) ratio of 12.01.

What is the Gland pharma's ticker?

Gland pharma trades on the NSE stock market in India under the ticker symbol "GLAND". Gland pharma’s stock symbol can also be displayed as "NSE:GLAND".

Who are the owners of Gland pharma?

Gland pharma (NSE:GLAND) is owned by 17.90% institutional shareholders and by 61.96% insiders. The rest is owned by the public.
Explore More Details on Gland pharma's “Ownership” Section

Who are the key executives of Gland pharma (GLAND)?

Gland pharma's key executive team includes the following managers:

Mr. Srinivas Sadu, MD, CEO & Director (1969)
Mr. Ravi Shekhar Mitra, Chief Financial Officer (1976)
Mr. Pallerlamudi Sampath Kumar, Company Sec. & Compliance Officer (1981)
Mr. Ashish Adhikari, VP of Operations (1975)
Mr. K. V.G.K. Raju, Chief Technical Officer (1951)
Mr. Sumanta Bajpayee, VP of Investor Relations (NA)
Mr. Susheel Ogra, Sr. Gen. Mang. of Sales & Marketing (1967)
Ms. Shilpi Sahay, Deputy Gen. Mang. of HR (1981)
Dr. C. S. Venkatesan, Sr. VP of R&D (1971)
Dr. Surapanini Sridevi, Sr. VP of R&D (1968)

What is Gland pharma’s Sector & Industry Classification?

Gland pharma (NSE:GLAND) is classified under the "Healthcare" sector and under the "Drug Manufacturers-General" industry.

How many employees work for Gland pharma?

Currently the number of employees working for Gland pharma is 3,961.

Where are Gland pharma's Headquarters?

Gland pharma (NSE:GLAND) is headquartered in India.

What are Gland pharma's Address and Phone Number?

Gland pharma’s mailing address is Plot No. 11 & 84, TSIIC Phase: IV, Hyderabad, India, 502307.
The company’s phone number is 91 84 5569 9999.

What is the official website for Gland pharma?

Gland pharma’s official website is http://www.glandpharma.com

Gland Pharma Stock (NSE:GLAND)